Moderna Rg
MRNA
USD
STOCK MARKET:
NMS
Open
 
...
Delayed quote
Last quote
03/28/2024 - 11:52:20
Bid
03/28/2024 - 11:52:24
Bid
Volume
Ask
03/28/2024 - 11:52:24
Ask
Volume
107.27
-3.32 ( -3.00% )
107.23
100
107.32
100
More information
Analysis by TheScreener
26.03.2024
Evaluation Neutral  
Interest Strong  
Sensibility Middle  
Analysis date: 26.03.2024
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 23.02.2024.
Interest
  Strong
Strong interest since 08.03.2024.
Earnings Rev Trend
  Positive
 
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 23.02.2024 at a price of 96.46.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, at its current price the stock is strongly overvalued.
MT Tech Trend
  Positive
 
The forty day Medium Term Technical Trend is positive since 23.02.2024. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 99.431.
4wk Rel Perf
  11.60%
 
The four week relative overperformance versus SP500 is 11.60%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 02.01.2024.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 4.80%.
Mkt Cap in $bn
  42.26
With a market capitalization >$8bn, MODERNA is considered a large-cap stock.
G/PE Ratio
  -0.03
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
  -41.49
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
  -1.05%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  21
Over the last seven weeks, an average of 21 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  105
For 1% of index variation, the stock varies on average by 1.05%.
Correlation
  0.28
Stock movements are strongly independent of index variations.
Value at Risk
  25.78
The value at risk is estimated at USD 25.78. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  29.03.2019